PD48-01: Efficacy of Nadofaragene Firadenovec-vncg for Patients With Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Final Results From a Phase 3 Trial
Sunday, May 5, 2024 1:00 PM to 1:10 PM · 10 min. (US/Central)
304A
Delete